An association study of cyclase-associated protein 2 and frailty.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
09 2023
Historique:
revised: 06 06 2023
received: 07 03 2023
accepted: 17 06 2023
medline: 14 9 2023
pubmed: 4 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

Frailty is a geriatric syndrome that results from multisystem impairment caused by age-associated accumulation of deficits. The frailty index is used to define the level of frailty. Several studies have searched for molecular biomarkers associated with frailty, to meet the needs for personalized care. Cyclase-associated protein 2 (CAP2) is a multifunctional actin-binding protein involved in various physiological and pathological processes, that might reflect frailty's intrinsic complexity. This study aimed to investigate the association between frailty index and circulating CAP2 concentration in 467 community-dwelling older adults (median age: 79; range: 65-92 years) from Milan, Italy. The selected robust regression model showed that circulating CAP2 concentration was not associated with chronological age, as well as sex and education. However, circulating CAP2 concentration was significantly and inversely associated with the frailty index: a 0.1-unit increase in frailty index leads to ~0.5-point mean decrease in CAP2 concentration. Furthermore, mean CAP2 concentration was significantly lower in frail participants (i.e., frailty index ≥0.25) than in non-frail participants. This study shows the association between serum CAP2 concentration and frailty status for the first time, highlighting the potential of CAP2 as a biomarker for age-associated accumulation of deficits.

Identifiants

pubmed: 37537790
doi: 10.1111/acel.13918
pmc: PMC10497846
doi:

Substances chimiques

Biomarkers 0
CAP2 protein, human 0
Membrane Proteins 0
Adaptor Proteins, Signal Transducing 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13918

Informations de copyright

© 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Proteomics. 2011 Oct 19;74(11):2313-23
pubmed: 21718814
Mol Biol Cell. 2004 May;15(5):2324-34
pubmed: 15004221
Sci Rep. 2015 Nov 30;5:17256
pubmed: 26616005
Am J Med Genet A. 2022 Mar;188(3):970-977
pubmed: 34862840
Age Ageing. 2014 Jan;43(1):10-2
pubmed: 24132852
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
Geriatr Gerontol Int. 2014 Apr;14(2):420-9
pubmed: 23879634
Aging Clin Exp Res. 2017 Feb;29(1):3-10
pubmed: 28155179
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Aging Cell. 2023 Sep;22(9):e13918
pubmed: 37537790
Clin Geriatr Med. 2017 Aug;33(3):293-303
pubmed: 28689563
Front Cell Dev Biol. 2020 Sep 24;8:586631
pubmed: 33072768
Brain Commun. 2020 Jun 26;2(2):fcaa086
pubmed: 33094279
Eur J Cell Biol. 2022 Apr;101(2):151207
pubmed: 35150966
J Med Genet. 2019 Apr;56(4):228-235
pubmed: 30518548
ScientificWorldJournal. 2001 Aug 08;1:323-36
pubmed: 12806071
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8397-8402
pubmed: 30962377

Auteurs

Silvia Pelucchi (S)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.

Chiara Macchi (C)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.

Laura D'Andrea (L)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.

Paolo Dionigi Rossi (PD)

Geriatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
General Medicine, Hospital San Leopoldo Mandic, Merate, Italy.

Michela Carola Speciani (MC)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Ramona Stringhi (R)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.

Massimiliano Ruscica (M)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.
Department of Cardio-Thoracic-Vascular Diseases, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.

Beatrice Arosio (B)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

Monica Di Luca (M)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.

Matteo Cesari (M)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

Valeria Edefonti (V)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Elena Marcello (E)

Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH